161 related articles for article (PubMed ID: 12111590)
1. Tissue levels, histologic changes and plasma pharmacokinetics of meta-Tetra (hydroxyphenyl) chlorin (mTHPC) in the cat.
Campbell GA; Bartels KE; Arnold C; Healey T; Cowell RL; Lucroy MD; Ronn AM
Lasers Med Sci; 2002; 17(2):79-85. PubMed ID: 12111590
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA
Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
4. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G
Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic properties of meta-tetra(hydroxyphenyl)chlorin in human tumor cells.
Melnikova VO; Bezdetnaya LN; Potapenko AY; Guillemin F
Radiat Res; 1999 Oct; 152(4):428-35. PubMed ID: 10477920
[TBL] [Abstract][Full Text] [Related]
7. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.
Lassalle HP; Dumas D; Gräfe S; D'Hallewin MA; Guillemin F; Bezdetnaya L
J Control Release; 2009 Mar; 134(2):118-24. PubMed ID: 19100297
[TBL] [Abstract][Full Text] [Related]
8. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
[TBL] [Abstract][Full Text] [Related]
9. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and bioactivity of tetra-pegylated meta-tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model.
Rovers JP; Saarnak AE; de Jode M; Sterenborg HJ; Terpstra OT; Grahn MF
Photochem Photobiol; 2000 Feb; 71(2):211-7. PubMed ID: 10687396
[TBL] [Abstract][Full Text] [Related]
11. Assessment of a sheep animal model to optimise photodynamic therapy in the oesophagus.
Glanzmann TM; Zellweger MP; Borle F; Conde R; Radu A; Ballini JP; Jaquet Y; Pilloud R; van den Bergh H; Monnier P; Andrejevic-Blant S; Wagnières GA
Lasers Surg Med; 2009 Nov; 41(9):643-52. PubMed ID: 19790242
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
[TBL] [Abstract][Full Text] [Related]
13. Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells.
Sasnouski S; Pic E; Dumas D; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L
Radiat Res; 2007 Aug; 168(2):209-17. PubMed ID: 17638401
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study.
Andrejevic Blant S; Ballini JP; van den Bergh H; Fontolliet C; Wagnières G; Monnier P
Photochem Photobiol; 2000 Mar; 71(3):333-40. PubMed ID: 10732452
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ
J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complexation with β-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin.
Yankovsky I; Bastien E; Yakavets I; Khludeyev I; Lassalle HP; Gräfe S; Bezdetnaya L; Zorin V
Eur J Pharm Sci; 2016 Aug; 91():172-82. PubMed ID: 27320407
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin.
Wagnieres G; Hadjur C; Grosjean P; Braichotte D; Savary JF; Monnier P; van den Bergh H
Photochem Photobiol; 1998 Sep; 68(3):382-7. PubMed ID: 9747593
[TBL] [Abstract][Full Text] [Related]
18. Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma.
Triesscheijn M; Ruevekamp M; Antonini N; Neering H; Stewart FA; Baas P
Photochem Photobiol; 2006; 82(6):1686-90. PubMed ID: 16984216
[TBL] [Abstract][Full Text] [Related]
19. Comparative biodistribution of meta-Tetra(Hydroxyphenyl) chlorin in multiple species: clinical implications for photodynamic therapy.
Ronn AM; Batti J; Lee CJ; Yoo D; Siegel ME; Nouri M; Lofgren LA; Steinberg BM
Lasers Surg Med; 1997; 20(4):437-42. PubMed ID: 9142684
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ
Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
